nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.184	0.228	CbGbCtD
Sulfadiazine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.128	0.159	CbGbCtD
Sulfadiazine—CYP2C8—Progesterone—uterine cancer	0.122	0.151	CbGbCtD
Sulfadiazine—CYP2C9—Progesterone—uterine cancer	0.0848	0.105	CbGbCtD
Sulfadiazine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0744	0.0923	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—uterine cancer	0.0728	0.0903	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—uterine cancer	0.0544	0.0675	CbGbCtD
Sulfadiazine—CYP3A4—Progesterone—uterine cancer	0.0493	0.0612	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—uterine cancer	0.0221	0.0274	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—uterine cancer	0.015	0.0187	CbGbCtD
Sulfadiazine—Muscle contracture—Dactinomycin—uterine cancer	0.0115	0.0596	CcSEcCtD
Sulfadiazine—Necrolysis epidermal—Etoposide—uterine cancer	0.00565	0.0294	CcSEcCtD
Sulfadiazine—Nephrotic syndrome—Medroxyprogesterone Acetate—uterine cancer	0.0047	0.0245	CcSEcCtD
Sulfadiazine—Hepatic necrosis—Progesterone—uterine cancer	0.00431	0.0225	CcSEcCtD
Sulfadiazine—Skin necrosis—Etoposide—uterine cancer	0.00367	0.0191	CcSEcCtD
Sulfadiazine—Nephritis interstitial—Medroxyprogesterone Acetate—uterine cancer	0.00337	0.0175	CcSEcCtD
Sulfadiazine—Neuritis—Progesterone—uterine cancer	0.00336	0.0175	CcSEcCtD
Sulfadiazine—Neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.0158	CcSEcCtD
Sulfadiazine—Tubulointerstitial nephritis—Medroxyprogesterone Acetate—uterine cancer	0.00297	0.0154	CcSEcCtD
Sulfadiazine—Eruption—Dactinomycin—uterine cancer	0.00288	0.015	CcSEcCtD
Sulfadiazine—Skin discolouration—Progesterone—uterine cancer	0.00278	0.0144	CcSEcCtD
Sulfadiazine—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.0142	CcSEcCtD
Sulfadiazine—Anuria—Epirubicin—uterine cancer	0.00206	0.0107	CcSEcCtD
Sulfadiazine—Skin necrosis—Epirubicin—uterine cancer	0.00206	0.0107	CcSEcCtD
Sulfadiazine—Vascular purpura—Progesterone—uterine cancer	0.00203	0.0106	CcSEcCtD
Sulfadiazine—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.0103	CcSEcCtD
Sulfadiazine—Anuria—Doxorubicin—uterine cancer	0.0019	0.00991	CcSEcCtD
Sulfadiazine—Skin necrosis—Doxorubicin—uterine cancer	0.0019	0.00991	CcSEcCtD
Sulfadiazine—Purpura—Progesterone—uterine cancer	0.00189	0.00983	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Progesterone—uterine cancer	0.00188	0.00979	CcSEcCtD
Sulfadiazine—Sulfathiazole—CYP19A1—uterine cancer	0.00183	1	CrCbGaD
Sulfadiazine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00951	CcSEcCtD
Sulfadiazine—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00891	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00887	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.0088	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Dactinomycin—uterine cancer	0.00166	0.00866	CcSEcCtD
Sulfadiazine—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00807	CcSEcCtD
Sulfadiazine—Sepsis—Dactinomycin—uterine cancer	0.00154	0.008	CcSEcCtD
Sulfadiazine—Skin discolouration—Etoposide—uterine cancer	0.00142	0.00739	CcSEcCtD
Sulfadiazine—Depression—Progesterone—uterine cancer	0.0014	0.00728	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Progesterone—uterine cancer	0.00137	0.00716	CcSEcCtD
Sulfadiazine—Body temperature increased—Carboplatin—uterine cancer	0.00135	0.00701	CcSEcCtD
Sulfadiazine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.0066	CcSEcCtD
Sulfadiazine—Hepatitis—Progesterone—uterine cancer	0.00126	0.00655	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00648	CcSEcCtD
Sulfadiazine—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00645	CcSEcCtD
Sulfadiazine—Skin exfoliation—Etoposide—uterine cancer	0.00122	0.00637	CcSEcCtD
Sulfadiazine—Erythema multiforme—Progesterone—uterine cancer	0.00119	0.0062	CcSEcCtD
Sulfadiazine—Tinnitus—Progesterone—uterine cancer	0.00117	0.00611	CcSEcCtD
Sulfadiazine—Eruption—Epirubicin—uterine cancer	0.00117	0.00608	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00116	0.00603	CcSEcCtD
Sulfadiazine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00594	CcSEcCtD
Sulfadiazine—Sepsis—Etoposide—uterine cancer	0.00111	0.00579	CcSEcCtD
Sulfadiazine—Eruption—Doxorubicin—uterine cancer	0.00108	0.00563	CcSEcCtD
Sulfadiazine—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00561	CcSEcCtD
Sulfadiazine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00554	CcSEcCtD
Sulfadiazine—Burning sensation—Epirubicin—uterine cancer	0.00103	0.00539	CcSEcCtD
Sulfadiazine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00533	CcSEcCtD
Sulfadiazine—Vertigo—Progesterone—uterine cancer	0.000985	0.00513	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.000983	0.00512	CcSEcCtD
Sulfadiazine—Stomatitis—Dactinomycin—uterine cancer	0.000966	0.00503	CcSEcCtD
Sulfadiazine—Neuritis—Epirubicin—uterine cancer	0.000963	0.00501	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Etoposide—uterine cancer	0.000962	0.00501	CcSEcCtD
Sulfadiazine—Burning sensation—Doxorubicin—uterine cancer	0.000958	0.00498	CcSEcCtD
Sulfadiazine—Convulsion—Progesterone—uterine cancer	0.00095	0.00494	CcSEcCtD
Sulfadiazine—Arthralgia—Progesterone—uterine cancer	0.000933	0.00486	CcSEcCtD
Sulfadiazine—Agranulocytosis—Dactinomycin—uterine cancer	0.000925	0.00482	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Progesterone—uterine cancer	0.000895	0.00466	CcSEcCtD
Sulfadiazine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000892	0.00464	CcSEcCtD
Sulfadiazine—Neuritis—Doxorubicin—uterine cancer	0.000891	0.00464	CcSEcCtD
Sulfadiazine—Hepatitis—Dactinomycin—uterine cancer	0.00089	0.00463	CcSEcCtD
Sulfadiazine—Blood disorder—Epirubicin—uterine cancer	0.000861	0.00448	CcSEcCtD
Sulfadiazine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000861	0.00448	CcSEcCtD
Sulfadiazine—Anorexia—Progesterone—uterine cancer	0.000853	0.00444	CcSEcCtD
Sulfadiazine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000846	0.0044	CcSEcCtD
Sulfadiazine—Erythema multiforme—Dactinomycin—uterine cancer	0.000842	0.00438	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000838	0.00436	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000815	0.00424	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00422	CcSEcCtD
Sulfadiazine—Insomnia—Progesterone—uterine cancer	0.000809	0.00421	CcSEcCtD
Sulfadiazine—Chills—Dactinomycin—uterine cancer	0.000799	0.00416	CcSEcCtD
Sulfadiazine—Blood disorder—Doxorubicin—uterine cancer	0.000797	0.00415	CcSEcCtD
Sulfadiazine—Skin discolouration—Epirubicin—uterine cancer	0.000796	0.00414	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000794	0.00413	CcSEcCtD
Sulfadiazine—Oliguria—Epirubicin—uterine cancer	0.00078	0.00406	CcSEcCtD
Sulfadiazine—Decreased appetite—Progesterone—uterine cancer	0.000778	0.00405	CcSEcCtD
Sulfadiazine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000773	0.00402	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Progesterone—uterine cancer	0.000772	0.00402	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000739	0.00384	CcSEcCtD
Sulfadiazine—Skin discolouration—Doxorubicin—uterine cancer	0.000737	0.00383	CcSEcCtD
Sulfadiazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.00382	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Progesterone—uterine cancer	0.000732	0.00381	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—uterine cancer	0.000722	0.00376	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000711	0.0037	CcSEcCtD
Sulfadiazine—Urticaria—Progesterone—uterine cancer	0.000711	0.0037	CcSEcCtD
Sulfadiazine—Abdominal pain—Progesterone—uterine cancer	0.000707	0.00368	CcSEcCtD
Sulfadiazine—Body temperature increased—Progesterone—uterine cancer	0.000707	0.00368	CcSEcCtD
Sulfadiazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000705	0.00367	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Etoposide—uterine cancer	0.000703	0.00366	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0007	0.00364	CcSEcCtD
Sulfadiazine—Stomatitis—Etoposide—uterine cancer	0.000699	0.00364	CcSEcCtD
Sulfadiazine—Leukopenia—Dactinomycin—uterine cancer	0.000694	0.00361	CcSEcCtD
Sulfadiazine—Skin exfoliation—Epirubicin—uterine cancer	0.000686	0.00357	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Epirubicin—uterine cancer	0.000675	0.00351	CcSEcCtD
Sulfadiazine—Agranulocytosis—Etoposide—uterine cancer	0.00067	0.00348	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000663	0.00345	CcSEcCtD
Sulfadiazine—Hypersensitivity—Progesterone—uterine cancer	0.000659	0.00343	CcSEcCtD
Sulfadiazine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000644	0.00335	CcSEcCtD
Sulfadiazine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00334	CcSEcCtD
Sulfadiazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00334	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—uterine cancer	0.000635	0.00331	CcSEcCtD
Sulfadiazine—Pruritus—Progesterone—uterine cancer	0.000633	0.00329	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—uterine cancer	0.000625	0.00325	CcSEcCtD
Sulfadiazine—Sepsis—Epirubicin—uterine cancer	0.000624	0.00325	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000619	0.00322	CcSEcCtD
Sulfadiazine—Diarrhoea—Progesterone—uterine cancer	0.000612	0.00319	CcSEcCtD
Sulfadiazine—Erythema multiforme—Etoposide—uterine cancer	0.000609	0.00317	CcSEcCtD
Sulfadiazine—Anorexia—Dactinomycin—uterine cancer	0.000603	0.00314	CcSEcCtD
Sulfadiazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000597	0.00311	CcSEcCtD
Sulfadiazine—Vascular purpura—Epirubicin—uterine cancer	0.000583	0.00304	CcSEcCtD
Sulfadiazine—Chills—Etoposide—uterine cancer	0.000578	0.00301	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—uterine cancer	0.000577	0.003	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000576	0.003	CcSEcCtD
Sulfadiazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000574	0.00298	CcSEcCtD
Sulfadiazine—Vomiting—Progesterone—uterine cancer	0.000569	0.00296	CcSEcCtD
Sulfadiazine—Rash—Progesterone—uterine cancer	0.000564	0.00294	CcSEcCtD
Sulfadiazine—Dermatitis—Progesterone—uterine cancer	0.000564	0.00293	CcSEcCtD
Sulfadiazine—Headache—Progesterone—uterine cancer	0.00056	0.00292	CcSEcCtD
Sulfadiazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000555	0.00289	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000553	0.00288	CcSEcCtD
Sulfadiazine—Decreased appetite—Dactinomycin—uterine cancer	0.00055	0.00286	CcSEcCtD
Sulfadiazine—Purpura—Epirubicin—uterine cancer	0.000542	0.00282	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—uterine cancer	0.00054	0.00281	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000539	0.00281	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Epirubicin—uterine cancer	0.000535	0.00278	CcSEcCtD
Sulfadiazine—Nausea—Progesterone—uterine cancer	0.000531	0.00277	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000517	0.00269	CcSEcCtD
Sulfadiazine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000515	0.00268	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000512	0.00266	CcSEcCtD
Sulfadiazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000511	0.00266	CcSEcCtD
Sulfadiazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000511	0.00266	CcSEcCtD
Sulfadiazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000508	0.00264	CcSEcCtD
Sulfadiazine—Vertigo—Etoposide—uterine cancer	0.000504	0.00262	CcSEcCtD
Sulfadiazine—Leukopenia—Etoposide—uterine cancer	0.000502	0.00261	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—uterine cancer	0.000501	0.00261	CcSEcCtD
Sulfadiazine—Body temperature increased—Dactinomycin—uterine cancer	0.0005	0.0026	CcSEcCtD
Sulfadiazine—Abdominal pain—Dactinomycin—uterine cancer	0.0005	0.0026	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000499	0.0026	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000495	0.00258	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—uterine cancer	0.000491	0.00255	CcSEcCtD
Sulfadiazine—Convulsion—Etoposide—uterine cancer	0.000486	0.00253	CcSEcCtD
Sulfadiazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000482	0.00251	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00047	0.00245	CcSEcCtD
Sulfadiazine—Hypersensitivity—Dactinomycin—uterine cancer	0.000466	0.00242	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Etoposide—uterine cancer	0.000458	0.00238	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—uterine cancer	0.000454	0.00236	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Etoposide—uterine cancer	0.000448	0.00233	CcSEcCtD
Sulfadiazine—Pancreatitis—Epirubicin—uterine cancer	0.000442	0.0023	CcSEcCtD
Sulfadiazine—Anorexia—Etoposide—uterine cancer	0.000436	0.00227	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000435	0.00226	CcSEcCtD
Sulfadiazine—Diarrhoea—Dactinomycin—uterine cancer	0.000433	0.00225	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—uterine cancer	0.000409	0.00213	CcSEcCtD
Sulfadiazine—Vomiting—Dactinomycin—uterine cancer	0.000402	0.00209	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000399	0.00208	CcSEcCtD
Sulfadiazine—Rash—Dactinomycin—uterine cancer	0.000399	0.00207	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—uterine cancer	0.000398	0.00207	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000395	0.00206	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000394	0.00205	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—uterine cancer	0.000392	0.00204	CcSEcCtD
Sulfadiazine—Nausea—Dactinomycin—uterine cancer	0.000376	0.00195	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—uterine cancer	0.000375	0.00195	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—uterine cancer	0.000374	0.00195	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000369	0.00192	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000365	0.0019	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—uterine cancer	0.000364	0.00189	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—uterine cancer	0.000363	0.00189	CcSEcCtD
Sulfadiazine—Abdominal pain—Etoposide—uterine cancer	0.000362	0.00188	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—uterine cancer	0.000362	0.00188	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—uterine cancer	0.000361	0.00188	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000347	0.00181	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—uterine cancer	0.000341	0.00178	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—uterine cancer	0.000337	0.00175	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—uterine cancer	0.000337	0.00175	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—uterine cancer	0.000334	0.00174	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—uterine cancer	0.000324	0.00169	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—uterine cancer	0.000324	0.00169	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—uterine cancer	0.000316	0.00164	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—uterine cancer	0.000313	0.00163	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—uterine cancer	0.000312	0.00162	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—uterine cancer	0.0003	0.00156	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—uterine cancer	0.000291	0.00151	CcSEcCtD
Sulfadiazine—Rash—Etoposide—uterine cancer	0.000289	0.0015	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—uterine cancer	0.000288	0.0015	CcSEcCtD
Sulfadiazine—Headache—Etoposide—uterine cancer	0.000287	0.00149	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—uterine cancer	0.000282	0.00147	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—uterine cancer	0.000281	0.00146	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—uterine cancer	0.000272	0.00142	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—uterine cancer	0.000272	0.00141	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—uterine cancer	0.000268	0.00139	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—uterine cancer	0.000261	0.00136	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—uterine cancer	0.00026	0.00135	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—uterine cancer	0.000257	0.00134	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—uterine cancer	0.000252	0.00131	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—uterine cancer	0.000251	0.00131	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—uterine cancer	0.000248	0.00129	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—uterine cancer	0.000245	0.00127	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000237	0.00124	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000234	0.00122	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000232	0.00121	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—uterine cancer	0.000232	0.00121	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—uterine cancer	0.000226	0.00118	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—uterine cancer	0.000223	0.00116	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000221	0.00115	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000216	0.00113	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—uterine cancer	0.000215	0.00112	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—uterine cancer	0.00021	0.00109	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—uterine cancer	0.000206	0.00107	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000205	0.00107	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—uterine cancer	0.000204	0.00106	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—uterine cancer	0.000203	0.00106	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—uterine cancer	0.000203	0.00106	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000194	0.00101	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—uterine cancer	0.000189	0.000984	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—uterine cancer	0.000189	0.000981	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—uterine cancer	0.000188	0.000977	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—uterine cancer	0.000188	0.000977	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—uterine cancer	0.000181	0.000945	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—uterine cancer	0.000176	0.000913	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—uterine cancer	0.000175	0.00091	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—uterine cancer	0.000168	0.000874	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—uterine cancer	0.000163	0.000849	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—uterine cancer	0.000162	0.000845	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—uterine cancer	0.000162	0.000842	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—uterine cancer	0.000162	0.000841	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—uterine cancer	0.000161	0.000836	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—uterine cancer	0.000152	0.000793	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—uterine cancer	0.000151	0.000785	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—uterine cancer	0.00015	0.000779	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—uterine cancer	0.00015	0.000778	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—uterine cancer	0.000149	0.000774	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—uterine cancer	0.000141	0.000734	CcSEcCtD
